I'm 57 years old. I founded adoption.com in 1995, ran orphanages in Ethiopia, Kenya, and Haiti, and I carry two copies of the Alzheimer's gene. My mom has Alzheimer's, and her doctors had a decade of chances to protect her brain with estrogen. They didn't.

So I started reading. Every study. Every source. And I got angry at how much we actually know that never reaches the exam room.

That's SmartStrongAlive. Evidence-based women's health for the second half of life: hormones, strength, metabolism, brain health, longevity. No sponsors. No "consult your doctor" used as a reason to tell you nothing. The real research, in plain English, with citations you can look up yourself.

Because "it's just aging" was never a good enough answer. First issue is live. Come read it.

I'm not a doctor. I'm a patient with a BS in Medical Technology who has drawn blood, read primary literature for 30 years out of pure compulsion, and decided to write the briefing I wish someone had handed my mother. That's the whole pitch.

"Your labs are normal" is the sentence that's failed more women than almost any other. Normal for what reference range? Normal for a 30-year-old man? Normal isn't the same as optimal, and it definitely isn't the same as "fine." If you feel terrible and your labs are "normal," you're not crazy. You're under-investigated.

In 2002, one study scared a generation of doctors off estrogen. The fallout, by some estimates, is tens of thousands of preventable deaths from conditions estrogen protects against. We rarely count those deaths, because they don't look like a side effect. They look like "natural aging."

There's a cream that costs about as much as a copay, prevents recurrent UTIs, and treats genitourinary symptoms with almost no systemic absorption. Most women over 50 have never been offered it. The FDA still makes it carry a black-box warning it doesn't deserve. We need to talk about this one.

We measure men's testosterone reflexively and women's almost never, even though women make and need it too. When mine came up, my brain went from black and white to technicolor. That's not a metaphor I reach for lightly. It's the closest description I have.

Antidepressants are extraordinary for some people. They're also handed out for a flatness that isn't depression at all: it's a hormone problem wearing depression's clothes. If you've been medicated but not actually helped, this distinction might be the most useful thing you read this year.

In a published study, 20.4% of postmenopausal women on hormone pellets developed endometrial hyperplasia. That's 1 in 5. Most of them were never warned it was a risk. I'm pro-hormones and pro-informed. Those aren't in conflict.

Finding out I'm APOE4/4 (the highest-risk genetic profile for Alzheimer's) could have wrecked me. Instead it organized me. Genes load the gun; they don't pull the trigger. Here's everything I'm doing about it, and the research behind each choice.

If you know a woman who's been told her symptoms are "just stress" or "just aging" while she's quietly going under, send her here. That woman is exactly who I built this for. She doesn't know yet that there's a better conversation to be had.

Most menopause content is too clinical to be useful or too soft to be credible. SmartStrongAlive is neither. More evidence, not less. Said plainly, by someone who's furious on your behalf.

Welcome. I'm Annette, and I'm so glad you're here.

Quick version of why this group exists: I'm 57, I have a BS in Medical Technology, I founded adoption.com back in 1995, and I carry the highest-risk genetic profile for Alzheimer's. My mom has it now. Her doctors had years of chances to protect her brain and didn't, mostly because the research never reached them. That made me angry enough to start reading everything and writing it down plainly.

This group is the room where we talk it through together. Lab results that got waved off. Symptoms that got called "stress." The questions you wish you'd known to ask. No selling, no shaming, no "just consult your doctor" as a way to avoid saying anything real. Evidence, and each other.

To start: introduce yourself in the comments and tell us one thing you were told was "just aging" that you've started to suspect was something treatable.

I read every comment. Let's get into it.

I've been on an antidepressant for 30 years. It does its job. My depression is managed, and I'm grateful for that. But somewhere in my 40s a different thing crept in: a flatness, a quietness, the willingness to start things going dim. I thought I was just getting more realistic. I wasn't. I was adjusting the wrong lever for a decade.

This week's issue is about the gap between depression and the flatness an antidepressant was never designed to touch. If you've felt it, you're not imagining it.

The flatness has a name, and it isn't depression. It's anhedonia: the loss of the pull. Not sadness, not the inability to function. It's the dopamine signal that says go toward that, it's worth doing going quiet. It shows up as "I don't particularly feel like it" where enthusiasm used to be.

Women describe it to me in almost identical words: "I'm just less driven than I used to be." "I've become more of a settler." None of them call it anhedonia. None of them connect it to hormones. They connect it to aging, and then they move on, because what is there to do about aging? There's plenty. But you have to understand why first.

Here's the part I wish someone had explained to me ten years ago. Antidepressants like SSRIs and SNRIs work mainly on serotonin: mood stability, anxiety, emotional reactivity. Testosterone-deficiency anhedonia runs through a completely different system: dopamine.

These systems are neighbors, not the same building. An antidepressant working perfectly on serotonin will not touch the dopamine system. It isn't supposed to. So when a woman on an SSRI says she still feels flat, she's told to adjust her dose or switch drugs. Almost no one tells her the truth: your antidepressant is working correctly, and you have a separate problem in a different system that it can't address.

A 2024 UK observational study followed 510 women on testosterone therapy and tracked their response across every symptom category. The single most responsive symptom of all? Anhedonia, "loss of interest in most things," at 56%. Higher than libido, which is the one thing medicine mentions when it mentions testosterone at all.

Now the honest caveat, because I will always give it to you: this is observational data. It can't rule out placebo or healthy-user effects, and no randomized trial has ever made anhedonia a primary endpoint. But 56% as the top responder, in 500-plus women, in a peer-reviewed journal, is a signal that deserves the trial it's never been given.

If this sounds like you, the labs are the concrete next step, and you have to ask for the right one. Total testosterone, SHBG, and free testosterone by equilibrium dialysis. That last one is the gold standard, because the Endocrine Society has flatly stated that the cheap immunoassays at female-range levels are "neither analytically nor clinically useful."

Almost nobody in the patient-facing menopause space tells you this: there's a specific lab code for the accurate test. LabCorp 500726. Quest 36170. It's covered at most major labs, and you can often order it yourself, cash, for $15 to $30 instead of the $200 to $400 a clinic visit runs. The full breakdown is in this week's issue.

I want to talk about something this week that took me years to understand about my own body.

I've been on an antidepressant for three decades. It works. My depression is genuinely managed. And yet, somewhere in my 40s, a different thing settled in: a flatness. Not sadness, not the inability to function. Just the quiet loss of the pull toward things I used to chase. I told myself I was getting more realistic. More mature. I grieved my old drive and moved on.

Turns out that flatness has a name (anhedonia), and in a lot of women it isn't depression at all. It's a hormone problem wearing depression's clothes, running through the dopamine system that an antidepressant was never built to reach. Nobody connected those two facts for me. I had to find it myself.

I think a lot of us have a version of this story. A symptom that got handed a prescription, when the real cause was somewhere else entirely.

So I'll ask the group directly: have you ever been put on an SSRI for something that turned out to be hormonal?

I read every comment. Let's get into it.

In 2013, a Yale OB-GYN named Philip Sarrel published a calculation in the American Journal of Public Health. Between 18,601 and 91,610 women died prematurely in the decade after the 2002 WHI announcement, midpoint around 48,000. That's not an advocacy slogan. It's peer-reviewed. TIME ran the headline "Could Estrogen Have Saved 50,000 Lives?" The honest answer was yes.

Here's the part that makes me furious. Sarrel's paper is explicit: those excess deaths were "almost entirely owing to a decrease in coronary heart disease." Estrogen protects the heart of a 50-year-old woman. Take it away, and five years later she dies of a heart attack that gets filed under "cardiovascular disease." Nobody writes "stopped her estrogen in 2002" on a death certificate. So nobody counted.

Sarrel studied women who'd had hysterectomies, ages 50 to 59. Those women can take estrogen alone, no progestin. And estrogen-alone was the WHI arm that showed a survival advantage: an all-cause mortality hazard ratio of 0.73. Women who took it were 27% less likely to die in that window. After 2002, doctors stopped prescribing it to them too. They panicked and threw out the data that actually helped.

A Finnish group followed 432,775 women who stopped hormone therapy. Among women under 60 who'd been on it more than five years and then quit, cardiac death risk was 2.08 times the expected rate and stroke death risk was 3.22 times in the first year. Now think about the timing. July 2002, doctors pull prescriptions. Millions of women who'd been protected for years went cold turkey that August. The harm landed exactly when you'd predict.

The 50,000+ women who died after 2002 have no memorial. No registry, no names, no obituaries that name the cause. Compare that to 9/11: 2,977 deaths, and we know every name, we built a wall, we have the photos. These women's deaths were just as preventable, and in fact were predicted. They got nothing. Not because their lives mattered less, but because the cause of their deaths was invisible even to their own families.

The deepest fear was: what if estrogen feeds a survivor's cancer? In 2024, JAMA Oncology followed 49,237 women with breast cancer, 84% estrogen-receptor-positive. Women who used vaginal estrogen had a hazard ratio of 0.77 for dying of their cancer. The fear predicted a number above 1.0. It came back at 0.77. The fear wasn't just unproven. It pointed the wrong direction.

In July 2025, urologist Rachel Rubin stood before the FDA and said five words: "Your label tried to kill my mother." Her mom was in the ICU, needed vaginal estrogen to fight an ascending infection, and nurses, pharmacists, and doctors all refused because of a black box warning inherited from 2003 systemic-HRT data. The FDA removed that warning in November 2025. For 22 years, it was there.

I'm not telling you this to scare you off doctors. I'm telling you so you can walk in informed. Know the Sarrel number. Know that stopping HRT abruptly after five-plus years carries a first-year mortality spike, so ask before you comply. Know that the NAMS guidelines now say that for most healthy women under 60 within ten years of menopause, the benefits outweigh the risks. The reckoning is happening. Be part of it.

If you know a woman whose doctor still says "lowest dose, shortest time" as if it's settled science, or who got pulled off hormones because she'd "been on them long enough," send her this week's issue. The deaths from 2002 to 2025 are in the ledger and we can't undo them. The next woman is still here. She's who all of this is for.

I want to talk about 2002, because I think most of us are still living inside a decision that got made that year and never got corrected.

In July 2002, the Women's Health Initiative announcement hit, and within weeks doctors across the country stopped prescribing estrogen. Here's what the headlines left out. For women 50 to 59 taking estrogen alone, that same study showed a survival advantage, a 27% lower chance of dying in that window. The benefit got buried under the fear.

A Yale OB-GYN, Philip Sarrel, later put a number on the fallout: between 18,601 and 91,610 women died prematurely in the decade that followed, midpoint around 48,000, published in the American Journal of Public Health in 2013. The paper is blunt about the cause. It was "almost entirely" heart disease. Estrogen had been protecting their hearts. It got taken away, and they died of heart attacks that nobody connected back to the prescription that got cancelled.

I'm 57. I carry two copies of the Alzheimer's gene, my mom has Alzheimer's, and I've spent years reading this literature because the gap between what we know and what reaches the exam room keeps costing women their lives. This one made me angry, and I think it should make you angry too. Not afraid. Angry, and informed.

So I want to compare notes with this group. What did your doctor tell you about HRT risk? Let's compare notes.

There's a scene in The Wizard of Oz where the film goes from black and white to technicolor. A patient used exactly that line to describe her brain on testosterone, at an FDA hearing, in 2025. I'd use the same words for mine. Before, I was a dimmer version of myself. Flat. Foggy. Operating at partial capacity and calling it "getting older." Then someone checked the one hormone almost no doctor measures in women. That's not marketing language. It's the most accurate description I have.

Here's the difference nobody warned me about. For years, doing hard things took discipline: pushing a version of myself that didn't want to move. After testosterone, it became pull. I wake up wanting to get to the day, the way I did at 30. I finish things I start, not because I'm forcing it, but because the wanting came back. Discipline is push. This is pull. I hadn't realized how much that one distinction shapes the texture of a whole day until I felt it return.

I've been on an antidepressant for 30 years. It did its job on the serotonin side. But the flatness I couldn't shake wasn't serotonin. It was dopamine, downstream of a hormone my body had quietly stopped making enough of. SSRIs don't touch that pathway. So I was "treated" and still going under. If you've been medicated for depression and still feel like the color's been turned down, this might be the most useful thing you read this year.

My labs were normal. I was not fine. Those two things lived side by side for years. "Normal" measured the wrong fraction of the wrong hormone against a reference range that was never built for a woman who feels like a dimmer switch got left half-down. If you feel terrible and your labs are "normal," you're not crazy. You're under-investigated. I know, because I was both.

Here's what came back, specifically. At the gym, I stopped negotiating with myself to show up; I wanted to be there. In the morning, I woke up actually wanting to get out of bed, not in an "I should" way. And the creativity that built adoption.com from nothing in 1995, the kind that has you excited about a new business at 7am before coffee, came back online. I had lost all of that so gradually I'd stopped noticing. It returning is how I learned it had ever left.

I want to tell you about the exact moment I realized "this is just aging" had been lying to me for years.

I'm 57. For a long time I felt flat. Foggy. Like a dimmer version of myself. I'd wake up and have to talk myself into the day. Hard things took everything I had, and I chalked it up to getting older, to stress, to a busy life. I'd been on an antidepressant for 30 years, so I figured the flatness was just my baseline.

Then someone checked one hormone almost no doctor measures in women. Within weeks, the color came back. I woke up wanting to get out of bed. The gym stopped being a negotiation. The ideas came back, the kind that build companies. A patient at an FDA hearing called it going from black and white to technicolor, and I have never heard it described better.

I'm not telling you what to take. I'm telling you that "flat and foggy" had a mechanism, and "it's just aging" was hiding it. The brain science is coming. This week I just wanted to say the human part out loud.

So here's where we start: what's one symptom you've been told to just live with?

Last week I told you my brain went from black and white to technicolor on testosterone. A lot of you wrote back asking the obvious question: okay, but what do I actually DO with that? So this week is the receipts. The science, the exact labs to ask for, and the words to say at your appointment. Save this one.

Here's the fact that reorders the whole conversation: you make about four times more testosterone than estrogen. Four times. It's not a trace hormone you can ignore. It's foundational to your baseline biochemistry, and it starts dropping around age 25, falling roughly 50% by 40. That's before the hot flashes, before the cycle changes, before anything announces itself as menopause.

This is the trap. Most doctors order total testosterone. But your cells don't use total, they use free testosterone, the fraction not locked up by a protein called SHBG. A woman can have a "normal" total reading and a free testosterone near zero, feeling every symptom of deficiency, while her labs say she's fine. She isn't fine. She's being measured wrong.

Want to know why so many studies "failed" to find testosterone effects in women? The standard immunoassay is close to useless at female-range levels. On the Beckman assay, the correlation with the gold-standard method drops to R squared = 0.16 below 37.6 ng/dL. That means the test explains about 16% of the variance. You can't run a valid study with a thermometer that broken. The Endocrine Society has recommended LC-MS/MS for women since 2007. Most labs still don't do it by default.

A UK study of 510 women, the largest cohort ever assembled on non-sexual testosterone outcomes, found the symptom with the highest improvement rate wasn't libido. It was anhedonia, the loss of interest in things you used to care about: 56% improved. No randomized trial in history ever used anhedonia as a primary endpoint. They were measuring the corner of the room and calling the whole house empty.

Walk in and ask for these three together: total testosterone, free testosterone (specify equilibrium dialysis, the most accurate method), and SHBG. Morning draw for peak levels. Want the full picture? Add DHEA-S, estradiol, and FSH. This isn't exotic testing. It's just asking for the right thing, on purpose.

If you were on the pill for years, this one's for you. Synthetic estrogen tells your liver to crank out SHBG, by 200 to 300% with some formulations. And it can stay elevated for six months or more after you stop. So a 43-year-old who quit the pill last year, with testosterone already declining from age, can have free testosterone at the floor and labs that still read "normal." Ask specifically about SHBG persistence. Most doctors won't bring it up.

Every time someone says "we don't have enough safety data" on testosterone for women, I think of trans men, who've taken testosterone at roughly 10 times the dose for 30 to 50 years, published and tracked. The largest cohort (1,229 trans men, Dutch study) found a breast cancer rate one-fifth that of cisgender women. As Dr. Kelly Casperson put it to the FDA: we're fighting about whether to give someone a glass of water while watching people swim safely in the ocean for fifty years.

A general practitioner who hasn't trained in this may be unfamiliar with what's available, or uncomfortable prescribing off-label (and right now everything for women IS off-label, because the FDA never built the road). Find a menopause specialist instead. The North American Menopause Society has a provider finder at nams.org. You're not asking for a favor. You're asking for competence.

For decades the whole question got framed as "is this worth it for one more sexual episode a month?" That was a real quote, on the record, at the FDA. It's the wrong question, and it always was. Testosterone is a neurohormone for your brain, bones, muscle, and mitochondria. Libido improving is a downstream side effect of your brain working better. Ask the right question and the answer changes.

I want to make this week practical, because last week's "technicolor" post lit up the comments and a lot of you asked the same thing: what do I actually ask for?

So here it is, the short version. If you suspect low testosterone (fatigue sleep won't fix, brain fog, flat mood, low drive, muscle that won't build despite effort), ask for these three labs, drawn together, in the morning: total testosterone, free testosterone by equilibrium dialysis, and SHBG.

Why all three? Because most doctors only run total testosterone, and total is not what your cells use. Your cells use free testosterone, the part not bound up by a protein called SHBG. You can have a "normal" total and a free T near zero, and feel every symptom while your labs say you're fine. And if you were on the pill for years, ask specifically about SHBG persistence, because it can stay elevated for months after you stop and quietly tank your free testosterone.

One more thing: find a menopause specialist, not just a GP. Everything for women here is off-label right now (there are zero FDA-approved testosterone products for women in the US), so you want someone who actually knows the territory. NAMS has a finder at nams.org.

What's the one question you wish you'd asked at your last appointment?

There's a cream that costs about eleven dollars a month, prevents recurrent UTIs, and barely enters your bloodstream. Most women over 50 have never been offered it. For 22 years it carried an FDA black box warning it never deserved, copy-pasted from a 2003 study on a completely different drug. The FDA finally removed that warning in November 2025. Your gynecologist may not have gotten the memo yet. This week I'm writing about why.

In July 2025, Dr. Rachel Rubin, a urologist whose own postmenopausal mother nearly died of urosepsis in the ICU, stood before an FDA advisory panel and said five words: "Your label tried to kill my mother." Her mother's ICU team had refused to restart an eleven-dollar vaginal estrogen cream because of a black box warning that was scientifically wrong for that product. Four months later, the FDA removed it. Sometimes one furious daughter moves the whole system.

Here's the number that should end the breast cancer panic around vaginal estrogen. A Vagifem tablet delivers 10 micrograms of estradiol. That's micrograms, not milligrams. A standard systemic HRT patch delivers 50 to 200 micrograms per day into the bloodstream. The vaginal dose acts locally on the tissue, and blood levels afterward are often literally undetectable on standard assays. As the tissue heals, even less gets absorbed. This is not systemic hormone therapy. The risks don't transfer.

This is the one I can't stop thinking about. In postmenopausal women with recurrent UTIs, vaginal estrogen users died of urosepsis at 0.42 percent. Non-users died at 1.54 percent. That's close to a fourfold difference in death rate, for an infection that starts as a UTI and kills roughly 270,000 Americans a year. The fix is a local cream with 50 years of safety data. Ask for it. Tell your mother. Tell her doctor.

If a postmenopausal woman with recurrent UTIs gets told to "just use a lubricant," she's being palliated, not treated. Lubricants reduce friction and give temporary comfort. They do nothing for the underlying tissue. They don't lower vaginal pH, they don't restore the epithelial barrier, and they don't prevent UTIs. Telling her to use a lubricant is like telling someone with pneumonia to use cough drops. Lubricant is comfort. Vaginal estrogen is tissue restoration and infection prevention.

There's a cream that costs about eleven dollars a month. It prevents recurrent UTIs, treats the dryness and burning and urgency that so many of us were told was "just aging," and barely enters the bloodstream. The blood levels afterward are often undetectable.

Most women over 50 have never been offered it.

For 22 years it carried an FDA black box warning, the agency's most serious caution, listing breast cancer, stroke, and dementia. That warning was written in 2003 for systemic hormones swallowed into the bloodstream. It was copy-pasted onto a local cream where almost nothing gets absorbed. It was factually wrong for vaginal estrogen the entire time.

In July 2025, Dr. Rachel Rubin, a urologist whose own mother nearly died of urosepsis in an ICU when the staff refused to restart her cream, told an FDA panel: "Your label tried to kill my mother." In November 2025, the FDA finally removed the warning.

But labels change faster than habits. The oncologist trained in 2003 still has 2003 instincts. The pharmacist still flinches. Millions of women are still being told to "just use a lubricant," which does nothing for the underlying tissue and nothing to prevent the next infection.

I'm still angry about this one. So I want to hear from you.

Were you ever offered vaginal estrogen? What happened?